Semi-supervised deep learning based 3D analysis of the peripapillary region.
Journal
Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630
Informations de publication
Date de publication:
01 Jul 2020
01 Jul 2020
Historique:
received:
18
03
2020
revised:
30
04
2020
accepted:
01
05
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
Optical coherence tomography (OCT) has become an essential tool in the evaluation of glaucoma, typically through analyzing retinal nerve fiber layer changes in circumpapillary scans. Three-dimensional OCT volumes enable a much more thorough analysis of the optic nerve head (ONH) region, which may be the site of initial glaucomatous optic nerve damage. Automated analysis of this region is of great interest, though large anatomical variations and the termination of layers make the requisite peripapillary layer and Bruch's membrane opening (BMO) segmentation a challenging task. Several machine learning-based segmentation methods have been proposed for retinal layer segmentation, and a few for the ONH region, but they typically depend on either heavily averaged or pre-processed B-scans or a large amount of annotated data, which is a tedious task and resource-intensive. We evaluated a semi-supervised adversarial deep learning method for segmenting peripapillary retinal layers in OCT B-scans to take advantage of unlabeled data. We show that the use of a generative adversarial network and unlabeled data can improve the performance of segmentation. Additionally, we use a Faster R-CNN architecture to automatically segment the BMO. The proposed methods are then used for the 3D morphometric analysis of both control and glaucomatous ONH volumes to demonstrate the potential for clinical utility.
Identifiants
pubmed: 33014570
doi: 10.1364/BOE.392648
pii: 392648
pmc: PMC7510893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3843-3856Informations de copyright
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.
Déclaration de conflit d'intérêts
MVS: Seymour Vision, Inc. (I).
Références
N Engl J Med. 2009 Mar 12;360(11):1113-24
pubmed: 19279343
Biomed Opt Express. 2017 Jul 13;8(8):3627-3642
pubmed: 28856040
Comput Biol Med. 2019 Nov;114:103445
pubmed: 31561100
Am J Ophthalmol. 2013 Aug;156(2):218-227.e2
pubmed: 23768651
Biomed Opt Express. 2013 Jun 14;4(7):1133-52
pubmed: 23847738
Transl Vis Sci Technol. 2017 Feb 28;6(1):11
pubmed: 28275526
Front Neurosci. 2017 Jul 12;11:381
pubmed: 28747871
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Invest Ophthalmol Vis Sci. 2014 Jun 03;55(7):4378-93
pubmed: 24894400
Invest Ophthalmol Vis Sci. 2013 Apr 23;54(4):2864-71
pubmed: 23538060
Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):1852-60
pubmed: 22410561
Biomed Opt Express. 2019 Aug 01;10(8):4340-4352
pubmed: 31453015
J Neuroophthalmol. 2015 Sep;35 Suppl 1:S8-S21
pubmed: 26274837
Biomed Opt Express. 2017 Feb 01;8(3):1306-1318
pubmed: 28663830
Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):6720-8
pubmed: 21743015
IEEE Trans Pattern Anal Mach Intell. 2017 Jun;39(6):1137-1149
pubmed: 27295650
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT575-84
pubmed: 27547890
Opt Express. 2010 Aug 30;18(18):19413-28
pubmed: 20940837
Biomed Opt Express. 2017 Apr 27;8(5):2732-2744
pubmed: 28663902
Med Image Anal. 2017 Jan;35:570-581
pubmed: 27689896
Biomed Opt Express. 2020 Oct 15;11(11):6356-6378
pubmed: 33282495
Biomed Opt Express. 2019 Sep 12;10(10):5042-5058
pubmed: 31646029
J Glaucoma. 2019 Oct;28(10):889-895
pubmed: 31335553
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
IEEE Trans Med Imaging. 2008 Oct;27(10):1495-505
pubmed: 18815101
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):63-74
pubmed: 29313052
J Glaucoma. 2014 Aug;23(6):360-7
pubmed: 25075462
Biomed Opt Express. 2018 Jun 25;9(7):3244-3265
pubmed: 29984096
Am J Ophthalmol. 2008 Apr;145(4):598-603
pubmed: 18295183